TARA Form 144: Broker-listed sales by 667, L.P.

TARA reported a Form 144 notice covering proposed sales of common stock by holders, with Canaccord Genuity LLC listed as a broker.

Accepted by SEC EDGAR 03/06/2026 - 05:51 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

TARA reported a Form 144 notice covering proposed sales of common stock by holders, with Canaccord Genuity LLC listed as a broker. The filing lists three sales by 667, L.P. in the past three months: 02/24/2026 26,755 shares (proceeds $161,584.00), 02/25/2026 78,716 shares (proceeds $457,046.00), and 03/04/2026 35,173 shares (proceeds $220,151.00). The filing also shows broker information for 03/06/2026.

Insights

Securities Compliance Counsel

Form 144 lists broker-assisted sales by a holder and shows recent dispositions.

The filing documents broker involvement with Canaccord Genuity LLC and three recorded sales by 667, L.P. totaling 140,644 shares across February–March 2026 with stated proceeds of $838,781.00. This reflects reported dispositions rather than new issuance.

Regulatory implications are routine: a Form 144 provides notice for proposed sales under Rule 144. Subsequent SEC filings or trade records would show executed transactions; timing and remaining planned sales are not specified in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does TARA's Form 144 show about recent sales?

Answer: The Form 144 lists broker details and three sales by 667, L.P. totaling 140,644 shares across 02/24/2026, 02/25/2026, and 03/04/2026. The filing includes per-sale proceeds of $161,584.00, $457,046.00, and $220,151.00.

Who is the broker listed on the TARA Form 144?

Answer: Canaccord Genuity LLC is listed as the broker with an entry dated 03/06/2026. The filing shows broker contact information and references brokerage involvement for the securities to be sold in the notice.

Which holder is selling shares according to the filing?

Answer: The filing identifies 667, L.P. as the selling holder for the recorded dispositions on 02/24/2026, 02/25/2026, and 03/04/2026. Each sale lists share counts and gross proceeds for those dates.

Does the Form 144 indicate proceeds received by the issuer?

Answer: The Form 144 lists per-transaction proceeds for the selling holder (e.g., $457,046.00 on 02/25/2026); it does not state that the issuer receives proceeds. The entries reflect proceeds tied to the reported sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001551139
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Protara Therapeutics, Inc.
SEC File Number	001-36694
Address of Issuer	345 Park Avenue South Third Floor New York NEW YORK 10010
Phone	646-844-0337
Name of Person for Whose Account the Securities are To Be Sold	667, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Canaccord Genuity LLC 99 High Street, Suite 1200 Boston MA 02110	38277	223920.00	53587260	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/06/2026	See Remark 2	Broker			38277	03/06/2026	See Remark 2

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
667, L.P. 860 Washington Street, 3rd Floor New York NY 10014	Common Stock	02/24/2026	26755	161584.00
667, L.P. 860 Washington Street, 3rd Floor New York NY 10014	Common Stock	02/25/2026	78716	457046.00
667, L.P. 860 Washington Street, 3rd Floor New York NY 10014	Common Stock	03/04/2026	35173	220151.00

144: Remarks and Signature

Remarks	(1) 667, L.P. is affiliated with Baker Brothers Life Sciences, L.P. Baker Bros. Advisors LP serves as the investment adviser to 667, L.P. and Baker Brothers Life Sciences, L.P. Baker Brothers Life Sciences, L.P. is filing separately for the sale of 461,723 shares of common stock ("Common Stock") of Protara Therapeutics, Inc. (the "Issuer"), which along with the reported sales in this form by 667, L.P. totals 500,000 shares of Common Stock. (2) Common Stock borrowed from broker.
Date of Notice	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	By: BAKER BROS. ADVISORS LP, mgmt company and IA to 667, L.P., /s/ Scott L. Lessing, President
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)